| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/19/2012 | US20120093723 Nanocarrier compositions and methods |
| 04/19/2012 | US20120093722 Synthetic diblock copolypeptide hydrogels for use in the central nervous system |
| 04/19/2012 | US20120093717 Microsphere/nanofiber composites for delivery of drugs, growth factors, and other agents |
| 04/19/2012 | US20120093716 Use of antisecretory factors (af) for optimizing cellular uptake |
| 04/19/2012 | US20120090604 Synthesis of small particles |
| 04/19/2012 | CA2814670A1 Egfr-based peptides |
| 04/19/2012 | CA2814500A1 Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate |
| 04/19/2012 | CA2814428A1 Antimicrobial protein |
| 04/19/2012 | CA2813344A1 Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material |
| 04/19/2012 | CA2813087A1 Engineered polypeptides having enhanced duration of action |
| 04/19/2012 | CA2813038A1 Highly soluble leptins |
| 04/19/2012 | CA2812948A1 Nd2 peptides and methods of treating neurological disease |
| 04/19/2012 | CA2812909A1 Compositions and methods for augmenting kidney function |
| 04/19/2012 | CA2812643A1 Method for purification of complement factor h |
| 04/19/2012 | CA2811752A1 Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseases |
| 04/19/2012 | CA2810999A1 Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients |
| 04/19/2012 | CA2807036A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases |
| 04/19/2012 | CA2801332A1 New emd formulation comprising pga |
| 04/18/2012 | EP2441774A1 Peptides having zinc finger domains and uses thereof |
| 04/18/2012 | EP2441477A1 Wound-covering material |
| 04/18/2012 | EP2441474A1 Methods and compositions for modulating adipocyte function |
| 04/18/2012 | EP2441467A1 Combination therapy for treating protein deficiency disorders |
| 04/18/2012 | EP2441466A1 Method for modulating appetite |
| 04/18/2012 | EP2441465A1 Compositions and methods for healthy pregnancy |
| 04/18/2012 | EP2441464A1 Specific therapy and medicament using integrin ligands for treating cancer |
| 04/18/2012 | EP2441460A1 GLP-1 pharmaceutical compositions |
| 04/18/2012 | EP2441449A1 Modulation of apolipoprotein C-III expression |
| 04/18/2012 | EP2441443A1 Lactoferrin based complex coacervates and their uses |
| 04/18/2012 | EP2440581A1 Fusion proteins for delivery of gdnf and bdnf to the central nervous system |
| 04/18/2012 | EP2440577A1 Truncated actriib-fc fusion proteins |
| 04/18/2012 | EP2440576A1 Methods for increasing thermogenic adipocytes |
| 04/18/2012 | EP2440570A2 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
| 04/18/2012 | EP2440569A1 Melanocortin receptor-specific peptides |
| 04/18/2012 | EP2440251A1 Administration of interferon for prophylaxis against or treatment of pathogenic infection |
| 04/18/2012 | EP2440241A1 Growth hormone polypeptides and methods of making and using same |
| 04/18/2012 | EP2440240A1 Use of lcat for treating anemia and red blood cell dysfunction |
| 04/18/2012 | EP2440239A1 Hemoglobin compositions |
| 04/18/2012 | EP2440238A1 Methods of treatment |
| 04/18/2012 | EP2440237A1 Treatment of coagulopathy with hyperfibrinolysis |
| 04/18/2012 | EP2440236A1 Neuregulin based methods for treating heart failure |
| 04/18/2012 | EP2440235A1 Glp-1 and fgf21 combinations for treatment of diabetes type 2 |
| 04/18/2012 | EP2440234A2 Immunological targeting of pathological tau proteins |
| 04/18/2012 | EP2440233A1 Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto |
| 04/18/2012 | EP2440232A1 Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders |
| 04/18/2012 | EP2440231A2 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| 04/18/2012 | EP2440230A2 Model systems and treatment regimes for treatment of neurological disease |
| 04/18/2012 | EP2440229A1 Compounds acting as peptide gap junction modulators, and uses thereof |
| 04/18/2012 | EP2440228A1 Glucose-regulating polypeptides and methods of making and using same |
| 04/18/2012 | EP2440227A2 Melanocortin receptor-specific peptides |
| 04/18/2012 | EP2440226A1 Vaccine therapy for choroidal neovascularization |
| 04/18/2012 | EP2440225A1 Novel applications of hip/pap or derivatives thereof |
| 04/18/2012 | EP2440184A2 Diketopiperazine microparticles with defined specific surface areas |
| 04/18/2012 | EP2440180A2 Ipamorelin diacetate injection and infusion solutions |
| 04/18/2012 | EP2231701B1 Peptidomimetics with glucagon antagonistic and glp-1 agonistic activities |
| 04/18/2012 | EP2222326B1 Inhibitors of MALT1-proteolytic activity and uses thereof |
| 04/18/2012 | EP2197477B1 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s) |
| 04/18/2012 | EP2170938B1 Rtef-1 variants and the use thereof for inhibition of angiogenesis |
| 04/18/2012 | EP2112998B1 Rgd containing recombinant gelatin |
| 04/18/2012 | EP2083855B1 Measles virus nucleoprotein for treating atherosclerosis |
| 04/18/2012 | EP1817066B1 Medical device for delivering biologically active material |
| 04/18/2012 | EP1676860B1 Process for producing antithrombin III composition |
| 04/18/2012 | EP1641486B1 Stable, aqueous solution of human erythropoietin, not containing serum albumin |
| 04/18/2012 | EP1594531B1 Storage-stable and bio-stable formulations of ACE inhibitors, and methods for preparation thereof |
| 04/18/2012 | EP1563300B1 Diagnostic method for celiac sprue |
| 04/18/2012 | EP1534750B1 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 04/18/2012 | EP1499358B1 Ph-sensitive polymer |
| 04/18/2012 | EP1456380B1 Smad7 inhibitors for the treatment of cns diseases |
| 04/18/2012 | EP1207876B9 Use of a modulator which acts on a growth factor precursor in order to inhibit growth factor precursor processing |
| 04/18/2012 | EP1183368B1 Proteinfragmente die verschiedene epitope der hpv proteine e6 und e7 umfassen, ihre herstellung und verwendungen insbesondere zur impfung |
| 04/18/2012 | EP1005488B9 Receptor that binds trail |
| 04/18/2012 | EP0618925B2 Antisense oligonucleotides |
| 04/18/2012 | CN1958601B 八棱丝瓜蛋白1的快速分离纯化及其晶体生长技术 Luffaculin Rapid Purification and crystal growth technology 1 |
| 04/18/2012 | CN1813699B Medicinal composition |
| 04/18/2012 | CN102421789A Target-specific non-antibody protein and method for preparing the same |
| 04/18/2012 | CN102421447A 用peg标记干扰素的方法 Labeled with a peg interferon method |
| 04/18/2012 | CN102421444A 用于治疗瘘的自体和异体脂肪来源的基质干细胞组合物 For the treatment of autologous and allogeneic adipose-derived stromal stem cells fistula composition |
| 04/18/2012 | CN102417540A Polyethylene glycol-modified integrin blocking agent HM-3 and application thereof |
| 04/18/2012 | CN102417539A 抗菌蛋白及编码基因、表达体系、复性系统和应用 Antibacterial proteins and coding genes, expression systems, complex systems and applications |
| 04/18/2012 | CN102417537A Proteins comprising conserved regions of neisseria meningitidis surface antigen nhha |
| 04/18/2012 | CN102416226A 用于治疗皮肤病学状况的装置 Apparatus for the treatment of dermatological condition |
| 04/18/2012 | CN102416176A Stabile isotonic lyophilized protein formulation |
| 04/18/2012 | CN102416172A 一种通过吸入给药的舍雷肽酶制剂 One kind of administration by inhalation serrapeptase preparation |
| 04/18/2012 | CN102416171A 高纯度凝血酶原复合物制品干热病毒灭活过程中的保护剂 High purity prothrombin complex products dry heat viral inactivation process protection agents |
| 04/18/2012 | CN102416170A 多酶片的生产工艺 Multienzyme production process |
| 04/18/2012 | CN102416169A 一种用于家禽消化道疾病的组合物 A composition for digestive diseases of poultry |
| 04/18/2012 | CN102416168A 干扰素α与氨溴索的雾化吸入剂 Interferon α and ambroxol inhalation agents |
| 04/18/2012 | CN102416167A 干扰素α与硫酸特布他林的雾化吸入剂 Interferon α and terbutaline sulfate inhalation agents |
| 04/18/2012 | CN102416166A 干扰素α与异丙脱溴铵的雾化吸入剂 Interferon α and isopropyl bromide inhalation off agent |
| 04/18/2012 | CN102416165A 干扰素α与地塞米松磷酸钠的雾化吸入剂 IFN-α and dexamethasone sodium phosphate inhalation agents |
| 04/18/2012 | CN102416164A 白细胞介素-27在制备抗甲型流感病毒药物中的应用 Interleukin -27 in the preparation of anti-influenza virus medicine |
| 04/18/2012 | CN102416163A 一种含有植物血球凝集素或植物血球凝集素亚型的组合物 Containing phytohemagglutinin or phytohemagglutinin subtype composition |
| 04/18/2012 | CN102416162A 一种经口腔粘膜吸收的还原型谷胱甘肽药物 One kind of oral mucosal absorption of glutathione drug |
| 04/18/2012 | CN102416001A 一种注射用醋酸奥曲肽冻干粉针剂及其制备方法 An injection of octreotide acetate freeze-dried powder and its preparation method |
| 04/18/2012 | CN101899104B 一种鲨鱼软骨血管生成抑制因子小分子多肽及其生产纯化方法和应用 One kind of shark cartilage angiogenesis inhibitor purified small peptides and their production methods and applications |
| 04/18/2012 | CN101879308B 人尿激肽原酶在制备治疗急性肾衰药物中的应用 Human urine kallikrein in the preparation of a medicament for the treatment of acute renal failure Application |
| 04/18/2012 | CN101829048B 一种滴眼液及其制备方法 One kind of eye drops and its preparation method |
| 04/18/2012 | CN101828661B 一种用于改善皮肤水分、除皱的保健食品 A method for improving skin moisture, wrinkle health food |
| 04/18/2012 | CN101703765B 一种延缓衰老的含片的制作方法 One kind of anti-aging tablet production method |
| 04/18/2012 | CN101648007B 一种用于治疗下肢溃疡的药物组合物及其制备方法 A pharmaceutical composition for the treatment of lower extremity ulcers and preparation method |
| 04/18/2012 | CN101591335B N-(l-氨基酰)-1,2,3,4-四氢咔啉酰氨基酸苄酯及其合成方法及应用 N- (l- amino acid), 2,3,4-tetrahydrocarboline amino acid benzyl ester synthesis method and its application |